Synairgen Plc (SNG.L) Share Price & News
Bid
--
-
Ask
- High-
- OPEN-
- VOL-
- MKT CAP-M
- LOW-
- CLOSE-
- SHARES IN ISSUE201.38M
Synairgen Plc Company Profile
Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.
The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned international academic Key Opinion Leader network to discover and develop novel therapies for respiratory disease.